Company / Net Debt per Share
CG Oncology, Inc. Net Debt per Share History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.38
FY2025
5-year range
-$4.11 / -$0.38
FY2024-FY2025
Trend
+90.7%
vs FY2024
Sector context
#56 of 82
Health Care
What the data says
At $-0.38, CG Oncology, Inc.'s net debt per share ranks #27 of 82 in the Health Care sector.
Based on SEC 10-K filings.
-0.38 in FY2025.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#27 of 82 in Health CareTop 32% of 82This company -$0.38 Sector average $13.62
▼
-102.8% below sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 90.7% year-over-year.
- Ranks #56 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.38 | +90.7% |
| FY2024 | -$4.11 | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026